WHO ICTRP trial
To assess the role of human placental extract in treating periodontitis
CTRI/2024/07/070472 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/07/070472 |
|---|---|
| Public title | To assess the role of human placental extract in treating periodontitis |
| Scientific title | Effects of Professional Mechanical Plaque Removal and Human Placental Extract on Gingival Crevicular Fluid levels of Matrix Metalloproteinase-8 in Patients with Stage II Grade A/B Periodontitis |
| Primary sponsor | Tamil Selvan M D |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: K053- Chronic periodontitis |
| Interventions | Intervention1: Human Placental extract: Placentrex – the original research product of Albert David Limited, India, a drug obtained from fresh term healthy human placentae will be placed as a Local drug delivery at Baseline Control… |
| Registration date | Nov 7, 2024 |
| Target size | 46 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: